Kirk Lane Pappan

Title: Kirk Lane Pappan: Innovator in Mass Spectrometry and Biomarkers

Introduction

Kirk Lane Pappan is a notable inventor based in Rougemont, NC (US). He has made significant contributions to the field of mass spectrometry and biomarkers, holding a total of 2 patents. His work focuses on methods that enhance the detection and quantification of metabolites related to liver function and insulin resistance.

Latest Patents

Pappan's latest patents include a mass spectrometry assay method for the detection and quantitation of liver function metabolites. This innovative method allows for the determination of various analytes in a sample, including 12,13-DiHOME, 3-hydroxybutyrate, and several others. The process involves subjecting the sample to an ionization source to produce detectable ions, measuring these ions, and using the data to ascertain the amount of each analyte present. Another significant patent addresses biomarkers related to insulin resistance progression. This patent provides methods for utilizing these biomarkers to monitor conditions such as dysglycemia, type-2 diabetes, and cardiovascular disease.

Career Highlights

Kirk Pappan is currently associated with Metabolon, Inc., where he applies his expertise in metabolomics. His work has been instrumental in advancing the understanding of metabolic disorders and their biomarkers. Pappan's innovative approaches have contributed to the development of new diagnostic methods that can significantly impact patient care.

Collaborations

Pappan has collaborated with notable colleagues, including Walter Gall and Jeffery Edmond Cobb. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of metabolomics.

Conclusion

Kirk Lane Pappan is a distinguished inventor whose work in mass spectrometry and biomarkers has the potential to transform the landscape of medical diagnostics. His contributions are vital for advancing our understanding of metabolic health and disease.